Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More
Xconomy
JULY 1, 2016
. —In the pink slip department, Cambridge-based Infinity Pharmaceuticals (NASDAQ: INFI ) announced 100 layoffs , more than half its workforce, after it terminated its partnership with AbbVie (NYSE: NYSE ) around the cancer drug duvelisib.
Let's personalize your content